Knights Of Columbus Asset Advisors LLC Denali Therapeutics Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.48 Billion
- Q3 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 39,119 shares of DNLI stock, worth $945,897. This represents 0.08% of its overall portfolio holdings.
Number of Shares
39,119
Previous 57,995
32.55%
Holding current value
$945,897
Previous $1.35 Million
15.38%
% of portfolio
0.08%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding DNLI
# of Institutions
228Shares Held
120MCall Options Held
60.6KPut Options Held
48.4K-
Baillie Gifford & CO13.3MShares$323 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$319 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$270 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$259 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$191 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.24B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...